Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma
NCT01453101
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
54
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
Fludarabine monophosphate, melphalan, Bortezomib
Sponsor
Hackensack Meridian Health